+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

(+)-Secoisolariciresinol

BP2266
145265-02-7
98%
Phytopurify
Secoisolariciresinol is an enterolignan precursor, it has antioxidant, and estrogen-like activities, it can significantly suppress triglyceride (TG) accumulation in 3T3-L1 adipocytes. Secoisolariciresinol prevents d-GalN/LPS-induced hepatic injury by inhibiting hepatocyte apoptosis through the blocking of TNF-alpha and IFN-gamma production by activated macrophages and direct inhibition of the apoptosis induced by TNF-alpha. (-)-Secoisolariciresinol exerts a suppressive effect on the gain of body weight of mice fed a high-fat diet by inducing gene expression of adiponectin, resulting in the altered expression of various genes related to the synthesis and β-oxidation of fatty acids. (+)-secoisolariciresinol is an enantiomer of secoisolariciresinol having (+)-(2S,3S)-configuration. It is an enantiomer of a (-)-secoisolariciresinol.
Catalog No Package Original Price Price Inventory Quantity Operating
BP2266-10mg 10mg
BP2266-20mg 20mg
BP2266-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related diseases

Related targets

TNF PTGS2 NFKB1 IL6 IL1B

(+)-Secoisolariciresinol Related Products

Product drug property prediction parameters

  • 99.3800

  • 2.1229

  • 2.1210

  • .3141

  • 4.7248

  • 4.1926

  • Low

  • 87.4523

  • 3.1122

  • No

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • Yes

  • No

  • No

  • No